Chemed Corporation (NYSE:CHE) Receives $574.25 Average Target Price from Brokerages

Shares of Chemed Corporation (NYSE:CHE) have been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $574.25.

CHE has been the subject of a number of recent research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Jefferies Financial Group raised Chemed from a “hold” rating to a “buy” rating and raised their price objective for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Royal Bank Of Canada lowered their price objective on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Finally, Bank of America reduced their target price on shares of Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a report on Wednesday, September 10th.

Chemed Stock Performance

Shares of NYSE:CHE opened at $435.26 on Wednesday. The stock’s 50-day simple moving average is $435.57 and its two-hundred day simple moving average is $459.77. The stock has a market capitalization of $6.16 billion, a price-to-earnings ratio of 23.02, a PEG ratio of 2.40 and a beta of 0.46. Chemed has a 52-week low of $408.42 and a 52-week high of $623.60.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing the consensus estimate of $5.39 by ($0.12). The business had revenue of $624.90 million during the quarter, compared to the consensus estimate of $626.04 million. Chemed had a return on equity of 25.89% and a net margin of 11.02%.Chemed’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter last year, the company earned $5.64 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, equities analysts forecast that Chemed will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Monday, November 17th were paid a $0.60 dividend. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s dividend payout ratio is 12.69%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 3,000 shares of the company’s stock in a transaction on Friday, September 26th. The shares were sold at an average price of $461.28, for a total value of $1,383,840.00. Following the completion of the transaction, the chief executive officer owned 96,197 shares of the company’s stock, valued at approximately $44,373,752.16. This represents a 3.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 3.29% of the company’s stock.

Hedge Funds Weigh In On Chemed

Hedge funds have recently made changes to their positions in the business. HighTower Advisors LLC raised its stake in Chemed by 6.3% during the 1st quarter. HighTower Advisors LLC now owns 2,452 shares of the company’s stock valued at $1,509,000 after purchasing an additional 145 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Chemed by 9.7% during the first quarter. Dimensional Fund Advisors LP now owns 218,675 shares of the company’s stock valued at $134,547,000 after buying an additional 19,421 shares during the last quarter. American Century Companies Inc. raised its position in shares of Chemed by 63.6% during the first quarter. American Century Companies Inc. now owns 6,508 shares of the company’s stock valued at $4,005,000 after buying an additional 2,531 shares during the last quarter. State of New Jersey Common Pension Fund D lifted its holdings in shares of Chemed by 5.0% in the first quarter. State of New Jersey Common Pension Fund D now owns 4,745 shares of the company’s stock worth $2,920,000 after buying an additional 226 shares in the last quarter. Finally, Cresset Asset Management LLC boosted its position in shares of Chemed by 7.4% during the first quarter. Cresset Asset Management LLC now owns 481 shares of the company’s stock worth $296,000 after acquiring an additional 33 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.